New China Life Insurance Company Ltd banner

New China Life Insurance Company Ltd
SSE:601336

Watchlist Manager
New China Life Insurance Company Ltd Logo
New China Life Insurance Company Ltd
SSE:601336
Watchlist
Price: 77.7 CNY -0.89% Market Closed
Market Cap: ¥242.4B

New China Life Insurance Company Ltd
Investor Relations

In the fast-evolving landscape of China's insurance sector, New China Life Insurance Company Ltd. (NCI) emerges as a compelling narrative of growth and adaptation. Founded in 1996 during a period when the nation was gradually embracing a market economy, NCI has navigated the tides of a transforming industry with agility and foresight. At its core, the company thrives by offering a robust portfolio of life insurance products that cater to an increasingly prosperity-conscious populace. Through diverse offerings like whole life, annuities, and health insurance, NCI meets the multifaceted financial protection needs of its clients. It has expanded its branches and service outlets across the country, integrating modern technology to enhance customer engagement and streamline its operations.

The company generates revenue through premium collections and strategic investment income. It pools the premiums from policyholders and invests in a wide range of asset classes from government bonds to equities, balancing risk and returns prudently. Simultaneously, it remains vigilant in its underwriting processes to minimize liabilities and fortify its fiscal strength. Moreover, NCI capitalizes on cross-selling opportunities by leveraging its wide agent network and digital platforms, which enhances its distribution efficiency. As China continues to urbanize and its middle-class burgeons, NCI is poised to deepen its market penetration, adapting to the shifting regulatory dynamics and demographic trends with strategic acumen, ensuring that it not only endures but thrives in the competitive insurance landscape.

Show more
Loading
601336
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2022
Call Date
Aug 31, 2022
AI Summary
Q2 2022

Revenue: Gross written premiums reached CNY 102.5 billion, up 2% year-on-year, showing steady growth despite industry headwinds.

Profit Drop: Net profit fell sharply by 50.8% due to lower investment income and market volatility.

Investment Performance: Annualized net investment yield improved to 4.7% (up 0.2 percentage points), while total investment yield declined to 4.2% (down 2.3 percentage points).

Bancassurance Strength: Bancassurance premiums grew 7.8% year-on-year, outpacing individual insurance channel and providing support amid a tough market.

Persistency Ratios: 13-month and 25-month persistency ratios decreased to 84.3% and 82.7%, respectively, reflecting pressure on policy renewals.

Agent Headcount: Sales agent count dropped by 27.9% year-on-year, but productivity per agent improved as the company focused on elite teams.

Embedded Value: Embedded value stayed essentially flat at CNY 258.8 billion, with new business value down 48.4%.

Strategic Focus: Management is pushing product innovation, digitalization, and expansion into health and aged care services as part of longer-term transformation.

Key Financials
Gross Written Premiums (GWP)
CNY 102.5 billion
Renewal Premiums
CNY 70.2 billion
Total Assets
CNY 1.18 trillion
Annualized Net Investment Yield
4.7%
Annualized Total Investment Yield
4.2%
Embedded Value
CNY 258.8 billion
New Business Value (NBV)
CNY 2.1 billion
Value of New Business (VNB) Margin (FYP)
6.6%
Value of New Business (VNB) Margin (APE)
12.8%
Agent Headcount
318,000
Monthly Average Qualified Agents
61,000
Monthly Average Qualified Rate
17.5%
13-month Persistency Ratio
84.3%
25-month Persistency Ratio
82.7%
Bancassurance Premiums
CNY 31.1 billion
Individual Insurance Channel Premiums
CNY 69.5 billion
Group Insurance Channel Premiums
CNY 1.8 billion
Short-term Insurance Premiums
CNY 2.8 billion
Other Earnings Calls
2022

Management

Mr. Yucheng Yang
Executive Chairman
No Bio Available
Mr. Xingfeng Gong
President, Financial Principal, VP, Chief Actuary, Board Secretary & Joint Company Secretary
No Bio Available
Mr. Hongbo Qin
VP & Chief Risk Officer
No Bio Available
Mr. Tao Zhang
Head of Accounting Department
No Bio Available
Mr. Zhongzhu Wang
GM of Discipline Inspection & Supervision Office and Employee Representative Supervisor
No Bio Available
Ms. Sau Mei Ng ACIS, ACS, FCIS, FCS
Joint Company Secretary
No Bio Available

Contacts

Address
BEIJING
Beijing
New China Life Insurance Mansion, No. A12, Jianguomenwai Avenue, Chaoyang District
Contacts